Hey John,
thank you for chiming in! And hats off regarding your analysis! Maybe I can add a little detail:
Signal intensity is a somewhat arbitrary value that an MRI scanner assigns to a voxel and is the result of biological (namely proton density - in humans, mostly water) but also technical aspects, so the value will be different from scanner to scanner. It has no real unit of measure, though there are some sequences (usually called mapping) that aim at creating objective, comparable measurements between scanners.
These signal intensities are rendered on the screen we use for reporting by assigning greyscale values; since the human eye can only discern so many different shades, we assign the values that routinely span intensities in the multiple hundreds into greyscale buckets, similar to CT, where we e.g. assign any value below -100 as completely black, no matter if -100 or -1000. The distribution of these assignments, and therefore how they appear on the screen depends on what we*re interested in and can vary wildly, so the same intensity can have vastly different “screen brightness” that we frequently adjust when reporting, which we call “windowing”. For LOINC, we’re therefore practically looking at an interval scale for all intents and purposes.
Now… it wasn’t my intention to cause work nobody else seems to need. That said, I suspect it might be a reasonable introduction, for the following reason:
Currently, LOINC has a code for measuring CT density of adrenals. This is because this measurement allows us to characterize a very common lesion called an adenoma in a large number of cases, because a low density of below 10 HU is considered diagnostic of an adenoma, rather than a more suspect lesion.
On MRI, we do something similar; we can’t measure density, but we can measure fat signal. A lesion loosing signal intensity if we suppress lipid signals would thus be considered an adenoma, and indeed, current guidelines name the use of MRI for characterizing lesions this way (the ESE 2023 guidelines, for instance).
Therefore, I’d argue that based on the inclusion of adrenal density measurement alone, the inclusion of measuring MRI signal intensity makes sense. It unquestioningly makes sense to have a more general code for CT density measurement outside of the adrenals, if there isn’t one - i couldn’t find it, but I still suspect i just overlooked it.
Does this make things more clear?